A system for treating a joint of a patient includes a treatment head including a probe, a force impulse wave sensor, and a pressure sensor. When the probe is pressed against the joint and reaches a predetermined pressure, the pressure sensor causes a release of current such that the probe delivers a mechanical force impulse to the joint. The force impulse wave sensor is configured to sense a frequency of the mechanical force impulse associated with a treatment point of the joint. The treatment head remains in the same target spot during the pre-test, treatment, and post-test. The system is configured to perform the pretest and post-test analysis of the plurality of treatment points to evaluate improvement of the joint after the treatment. The treatment protocol for the treatment point is modified based on the sensed frequency of the mechanical force impulse from the pre-test at the treatment point.

Disclosed examples include technology for the detection and treatment of neotissue formation proximate an implantable stimulator. Neotissue formation can include ossification, scar tissue, soft tissue fibrosis, and other tissue growth. The neotissue formation can be detected by analyzing (e.g., using a machine-learning framework) stimulation data relating to the implantable stimulator. Neotissue formation characteristics can be analyzed to determine appropriate treatment actions for ameliorating the effects of neotissue formation.

A terminal device includes: an information storage that stores registration information for establishing a wireless communication connection with an electrical treatment device; a detection unit that detects a beacon signal emitted from the electrical treatment device; a determination unit that determines, on the based on the registration information stored in the information storage unit and the beacon signal detect, whether the electrical treatment device includes an unregistered electrical treatment device. In a case where the unregistered electrical treatment device is included, the determination unit further determines, on the basis of the beacon signal detected, whether the unregistered electrical treatment device includes registration information of a device other than the terminal device. The terminal device further includes a notification unit that provides notification on information including a solution for an error when the electrical treatment device not registered with the terminal device includes the registration information of the device other than terminal device.

An unattended approach can increase the reproducibility and safety of the treatment as the chance of over/under treating of a certain area is significantly decreased. On the other hand, unattended treatment of uneven or rugged areas can be challenging in terms of maintaining proper distance or contact with the treated tissue, mostly on areas which tend to differ from patient to patient (e.g. facial area). Delivering energy via a system of active elements embedded in a flexible pad adhesively attached to the skin offers a possible solution. The unattended approach may include delivery of multiple energies to enhance a visual appearance.

An unattended approach can increase the reproducibility and safety of the treatment as the chance of over/under treating of a certain area is significantly decreased. On the other hand, unattended treatment of uneven or rugged areas can be challenging in terms of maintaining proper distance or contact with the treated tissue, mostly on areas which tend to differ from patient to patient (e.g. facial area). Delivering energy via a system of active elements embedded in a flexible pad adhesively attached to the skin offers a possible solution. The unattended approach may include delivering of multiple energies to enhance a visual appearance.

Described is a low voltage, pulsed electrical stimulation device (bioelectric stimulator associated with electrodes) for controlling expression of S100 protein(s) by cellular tissues. The bioelectric stimulator is useful in methods to treat a subject suffering from bladder, heart, and/or nerve tissue damage.

Systems, devices and methods are provided for transcutaneously delivering energy impulses to bodily tissues for therapeutic purposes, such as for enhancing the body's bone healing process in spinal fusion patients. A therapeutic stimulator system comprises a housing for an energy source and a signal generator. The system further includes one or more electrodes coupled to the signal generator. A processor is coupled to the housing and configured to determine usage levels of the signal generator and/or motion data of the housing. The system may include a mobile device that allows the patient to input user status data, such as pain levels, and compare the user status data with the usage levels and/or the motion data, thereby improving patient compliance with a prescribed therapy regimen.

Bioelectronic lens (E-lens) systems for inducing neuroprotective changes in neurons, in particular the retina. A system may include a stimulating electrode configured to be placed on an eye or skin around the eye. The system may further include a return electrode configured such that voltage distribution is focalized to the eye and induced electric fields to an area of interest on the eye or on the skin around the eye are maximized. The electric fields provide neuroprotection and reinnervation.

Provided are methods and devices for treating skin conditions using an electrical signal applied to the skin of a subject.

Systems, devices and methods are provided for transcutaneously delivering energy impulses to bodily tissues for therapeutic purposes, such as for enhancing the body's bone healing process in spinal fusion patients. A therapeutic stimulator system comprises a housing for an energy source and a signal generator. The system further includes one or more electrodes coupled to the signal generator. A processor is coupled to the housing and configured to determine usage levels of the signal generator and/or motion data of the housing. The system may include a mobile device that allows the patient to input user status data, such as pain levels, and compare the user status data with the usage levels and/or the motion data, thereby improving patient compliance with a prescribed therapy regimen.